Your browser doesn't support javascript.
loading
Hepatic artery stenosis after liver transplant: Donation after cardiac death donor vs donation after brain death donor grafts.
Lee, David D; Paz-Fumagalli, Ricardo; Croome, Kristopher P; Paz, Diego; Wright, Lauren; Nguyen, Justin H; Taner, C Burcin.
Afiliação
  • Lee DD; Department of Transplantation, Mayo Clinic Florida and Mayo Clinic Collaborative in Transplant Research and Outcomes, Jacksonville, Florida.
  • Paz-Fumagalli R; Department of Radiology, Mayo Clinic Florida, Jacksonville, Florida.
  • Croome KP; Department of Transplantation, Mayo Clinic Florida and Mayo Clinic Collaborative in Transplant Research and Outcomes, Jacksonville, Florida.
  • Paz D; Clinical Research Internship Study Program (CRISP) Mayo Clinic Florida, Jacksonville, Florida.
  • Wright L; Department of Transplantation, Mayo Clinic Florida and Mayo Clinic Collaborative in Transplant Research and Outcomes, Jacksonville, Florida.
  • Nguyen JH; Department of Transplantation, Mayo Clinic Florida and Mayo Clinic Collaborative in Transplant Research and Outcomes, Jacksonville, Florida.
  • Taner CB; Department of Transplantation, Mayo Clinic Florida and Mayo Clinic Collaborative in Transplant Research and Outcomes, Jacksonville, Florida.
Clin Transplant ; 32(11): e13413, 2018 11.
Article em En | MEDLINE | ID: mdl-30240491
BACKGROUND: Hepatic artery stenosis (HAS) after liver transplant (LT) is a source of significant morbidity. Some reports have suggested higher arterial complications in patients who receive donation after cardiac death (DCD) livers. METHODS: A total of 2860 consecutive LT were reviewed from a prospectively collected database. All angiograms performed in LT recipients were reviewed and primary patency rates determined by need for further intervention or graft loss due to HAT. RESULTS: Hepatic artery stenosis was seen in 4.6% of DCD and donation after brain death (DBD) recipients. Recipient male gender, age at transplant, complex donor hepatic artery anatomy, and prolonged operative time were all associated with HAS, but not DCD status. While HAS in recipients of DCD grafts required more stents (1.7% vs 0.6%, P = 0.04) and had worse primary patency rates (logrank, P = 0.02), outcomes as defined by HAT, patient and graft survival were not significantly different between the recipients of DCD or DBD grafts. CONCLUSION: We observed no significant difference in the incidence of hepatic artery complications, patient survival, or graft survival in recipients of DCD or DBD grafts. However, HAS in DCD recipients had worse primary patency and a higher need for stent placement.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doadores de Tecidos / Obtenção de Tecidos e Órgãos / Transplante de Fígado / Constrição Patológica / Seleção do Doador / Rejeição de Enxerto / Artéria Hepática Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doadores de Tecidos / Obtenção de Tecidos e Órgãos / Transplante de Fígado / Constrição Patológica / Seleção do Doador / Rejeição de Enxerto / Artéria Hepática Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article